IL17A and acute respiratory distress syndrome: Finally, in a mouse model of acute respiratory distress syndrome (ARDS) induced by poly (I:C) treatment, 5 mg/kg CBC was administered with an inhaler, and the therapeutic effect was confirmed by decreasing the expression of IL-6, IL-17, and IFN-γ [30].